Pontus Protein Cash Flow Statement

Financials in millions CAD. Fiscal year is December - November.

Millions CAD. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2019
Period Ending	Aug '22 Aug 31, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019
Net Income	-6.33	-8.75	-0.69	-0.55
Depreciation & Amortization	0.22	0.21	0.02	-
Asset Writedown & Restructuring Costs	0.75	0.75	-	-
Stock-Based Compensation	1.01	0.96	-	-
Other Operating Activities	5.15	5.12	-0.06	-
Change in Accounts Payable	1.36	1.11	0.33	0.03
Change in Other Net Operating Assets	-0.2	-0.32	-0.07	-0.52
Operating Cash Flow	1.95	-0.92	-0.48	-1.04
Capital Expenditures	-2.29	-3.19	-0.11	-
Sale (Purchase) of Intangibles	-0.06	-0.06	-	-
Investment in Securities	4.25	-0.03	-	-
Investing Cash Flow	1.9	-3.28	-0.11	-
Short-Term Debt Issued	-	-	0.11	-
Long-Term Debt Issued	-	0.24	0.04	-
Total Debt Issued	0.14	0.24	0.15	-
Long-Term Debt Repaid	-	-0.29	-0.01	-
Net Debt Issued (Repaid)	-0.1	-0.05	0.14	-
Issuance of Common Stock	-	2.13	0.46	1.04
Other Financing Activities	-4.12	-0.01	-	-
Financing Cash Flow	-5.43	2.06	0.6	1.04
Miscellaneous Cash Flow Adjustments	2.13	2.13	-	-
Net Cash Flow	0.55	0	0.01	-0
Free Cash Flow	-0.34	-4.1	-0.59	-1.04
Free Cash Flow Per Share	-0.00	-0.07	-0.02	-0.04
Cash Interest Paid	0.19	0.19	0.02	-
Levered Free Cash Flow	-	-2.86	-	-
Unlevered Free Cash Flow	-	-2.73	-	-
Change in Net Working Capital	-	-1.15	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.